Gi. Deichman et al., CELL TRANSFORMING GENES AND TUMOR PROGRESSION - IN-VIVO UNIFIED SECONDARY PHENOTYPIC CELL CHANGES, International journal of cancer, 75(2), 1998, pp. 277-283
We have earlier shown that Syrian hamster cells spontaneously transfor
med in vitro during in vivo progression, acquire in 1 step, along with
highly increased tumorigenicity, 2 new properties characterizing the
[H2O2CA + tPGE(S)] phenotype, i.e., a high H2O2 catabolizing (antioxid
ant) activity and the ability to release PGE(2) upon contact with NK c
ells. In contrast, RSV-SR-(v-src)-transformed cells acquire the [H2O2C
A + PGE(S)] phenotype and high tumorigenicity during in vitro transfor
mation, i.e., without preliminary in vivo selection. In the present st
udy, the possible influence of different transforming genes on the rat
es of subsequent in vivo tumor progression was studied using cells in
vitro transformed by SV40, BAV-3, or transduced by activated genes Ha-
ras, p53, myc and bcl-2. The expression of the [H2O2CA + PGE(S)] pheno
type, the extent of tumorigenic and spontaneous metastasizing activiti
es were examined before and during in vivo cells selection in s.c. gro
wing tumors. Our results demonstrate that: (1) after in vitro transfor
mation all cell lines (except v-src) were negative for the expression
of [H2O2CA + PGE(S)] phenotype and remained equally low-tumorigenic; (
2) independently of the types of genes initially transforming the cell
s, in vivo tumor progression was consistently leading to the replaceme
nt of parental cells by cells expressing the [H2O2CA + PGE(S)] phenoty
pe to 30-200 times increased tumorigenicity and less frequently to met
astasizing; (3) the time necessary for selection of cells expressing t
his phenotype was the same (about 180 days in vivo) for all transforma
nts, except bcl-2; the latter reaching similar values after a signific
ant delay. Thus, common secondary src-like phenotypic cell changes, re
gardless of initially cell transforming genes are necessarily selected
during tumor progression in vivo. (C) 1998 Wiley-Liss, Inc.